- Home
- COCP vs NMTC Comparison
COCP vs NMTC Comparison
Compare COCP & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- NMTC
- Stock Information
- Founded
- COCP N/A
- NMTC 2009
- Country
- COCP United States
- NMTC United States
- Employees
- COCP N/A
- NMTC N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- COCP Health Care
- NMTC Health Care
- Exchange
- COCP Nasdaq
- NMTC Nasdaq
- Market Cap
- COCP 20.1M
- NMTC 21.0M
- IPO Year
- COCP N/A
- NMTC N/A
- Fundamental
- Price
- COCP $1.98
- NMTC $1.05
- Analyst Decision
- COCP Strong Buy
- NMTC
- Analyst Count
- COCP 1
- NMTC 0
- Target Price
- COCP $7.00
- NMTC N/A
- AVG Volume (30 Days)
- COCP 93.7K
- NMTC 210.9K
- Earning Date
- COCP 11-13-2024
- NMTC 02-11-2025
- Dividend Yield
- COCP N/A
- NMTC N/A
- EPS Growth
- COCP N/A
- NMTC N/A
- EPS
- COCP N/A
- NMTC N/A
- Revenue
- COCP N/A
- NMTC $3,453,003.00
- Revenue This Year
- COCP N/A
- NMTC $292.88
- Revenue Next Year
- COCP N/A
- NMTC N/A
- P/E Ratio
- COCP N/A
- NMTC N/A
- Revenue Growth
- COCP N/A
- NMTC 1.33
- 52 Week Low
- COCP $1.33
- NMTC $0.55
- 52 Week High
- COCP $3.26
- NMTC $1.59
- Technical
- Relative Strength Index (RSI)
- COCP 44.30
- NMTC 61.82
- Support Level
- COCP $2.21
- NMTC $1.00
- Resistance Level
- COCP $2.60
- NMTC $1.28
- Average True Range (ATR)
- COCP 0.33
- NMTC 0.13
- MACD
- COCP -0.07
- NMTC 0.01
- Stochastic Oscillator
- COCP 4.81
- NMTC 56.19
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.